{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:21:12Z","timestamp":1790680872538,"version":"4.1.0"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Cutaneous squamous cell carcinoma (SCC) is the second most common type of skin cancer. Only 2% to 5% of SCCs metastasize; however, those do carry a poor prognosis. Immunohistochemistry (IHC) is widely used by pathologists to characterize skin cancers and provide clinically useful information.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To evaluate the potential prognostic associations between IHC findings and metastasis in SCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Searches were conducted in MEDLINE via PubMed for articles published between 1999 and 2019. Search criteria included key words \u201cimmunohistochemistry\u201d and \u201ccutaneous squamous cell carcinoma.\u201d Six hundred and fifty-three articles were returned and screened, which ultimately left 31 for inclusion in our manuscript.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Thirty-one articles analyzed in this review included a discussion of the expression of a particular IHC marker and the associated risk of metastasis and\/or clinical utility of IHC markers in SCC, especially metastatic SCC. Markers that had several or more studies supporting clinical utility were E-cadherin, podoplanin, CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells, PD-L1, epidermal growth factor receptor, and Cyclin D1.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Immunohistochemistry profiling of SCC may be useful in select cases when providing a prognosis remains challenging and in identification of potential therapeutic targets for high-risk or metastatic tumors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000002850","type":"journal-article","created":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T15:00:48Z","timestamp":1604847648000},"page":"313-318","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["The Correlation Between Immunohistochemistry Findings and Metastasis in Squamous Cell Carcinoma: A Review"],"prefix":"10.1097","volume":"47","author":[{"given":"Marissa","family":"Lobl","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Nebraska Medical Center, Omaha, Nebraska;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Grinnell","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Phillips","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Nebraska Medical Center, Omaha, Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Abels","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Wysong","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Nebraska Medical Center, Omaha, Nebraska;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.mayocp.2017.02.015","article-title":"Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: a population-based study in olmsted county, Minnesota, 2000 to 2010","volume":"92","author":"Muzic","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","article-title":"Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study","volume":"9","author":"Brantsch","year":"2008","journal-title":"Lancet Oncol"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1097\/01.mlg.0000173202.56739.9f","article-title":"Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck","volume":"115","author":"Moore","year":"2005","journal-title":"Laryngoscope"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/jso.23155","article-title":"The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors","volume":"106","author":"Brougham","year":"2012","journal-title":"J Surg Oncol"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"161-vii","DOI":"10.1016\/j.det.2011.02.006","article-title":"Mohs surgery for squamous cell carcinoma","volume":"29","author":"Belkin","year":"2011","journal-title":"Dermatol Clin"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/S0022215109991101","article-title":"Metastatic cutaneous squamous cell carcinoma of the external ear: a high-risk cutaneous subsite","volume":"124","author":"Turner","year":"2010","journal-title":"J Laryngol Otol"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamadermatol.2013.2456","article-title":"Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system","volume":"149","author":"Jambusaria-Pahlajani","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamadermatol.2013.6675","article-title":"Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system","volume":"150","author":"Schmitt","year":"2014","journal-title":"JAMA Dermatol"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/DSS.0000000000001828","article-title":"A retrospective cohort study of cutaneous squamous cell carcinoma with lymph node metastasis: risk factors and clinical course","volume":"45","author":"Feinstein","year":"2019","journal-title":"Dermatol Surg"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"a003129","DOI":"10.1101\/cshperspect.a003129","article-title":"Involvement of members of the cadherin superfamily in cancer","volume":"1","author":"Berx","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R","article-title":"Cadherin-catenin complex: protein interactions and their implications for cadherin function","volume":"61","author":"Aberle","year":"1996","journal-title":"J Cel Biochem"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4048\/jbc.2015.18.3.256","article-title":"Epithelial-mesenchymal transition phenotype is associated with clinicopathological factors that indicate aggressive biological behavior and poor clinical outcomes in invasive breast cancer","volume":"18","author":"Bae","year":"2015","journal-title":"J Breast Cancer"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1158\/0008-5472.CAN-16-3521","article-title":"Survival outcomes in cancer patients predicted by a partial EMT gene expression scoring metric","volume":"77","author":"George","year":"2017","journal-title":"Cancer Res"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3892\/ijmm.2011.640","article-title":"Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer","volume":"27","author":"Ling","year":"2011","journal-title":"Int J Mol Med"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1158\/1078-0432.CCR-04-1810","article-title":"Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis","volume":"11","author":"Shinozaki","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/cncr.23770","article-title":"Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma","volume":"113","author":"Marsit","year":"2008","journal-title":"Cancer"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jdermsci.2013.07.001","article-title":"Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases","volume":"72","author":"Toll","year":"2013","journal-title":"J Dermatol Sci"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1159\/000450920","article-title":"Characterisation of prognosis and invasion of cutaneous squamous cell carcinoma by podoplanin and E-cadherin expression","volume":"232","author":"Hesse","year":"2016","journal-title":"Dermatology"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"444","DOI":"10.5604\/01.3001.0011.7389","article-title":"Antiproliferative effects of epigenetic modifier drugs through E-cadherin up-regulation in liver cancer cell lines","volume":"17","author":"Uribe","year":"2018","journal-title":"Ann Hepatol"},{"key":"R20-20250731","first-page":"370","article-title":"Podoplanin - a small glycoprotein with many faces","volume":"6","author":"Ugorski","year":"2016","journal-title":"Am J Cancer Res"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1538-7836.2011.04335.x","article-title":"Novel platelet activation receptor CLEC-2: from discovery to prospects","volume":"9","author":"Suzuki-Inoue","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/cup.12859","article-title":"The expression of podoplanin is associated with poor outcome in cutaneous squamous cell carcinoma","volume":"44","author":"Ca\u00f1ueto","year":"2017","journal-title":"J Cutan Pathol"},{"key":"R23-20250731","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/jso.23238","article-title":"Podoplanin expression in cutaneous head and neck squamous cell carcinoma\u2014prognostic value and clinicopathologic implications","volume":"107","author":"Kreppel","year":"2013","journal-title":"J Surg Oncol"},{"key":"R24-20250731","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1186\/s12885-019-5808-9","article-title":"Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma","volume":"19","author":"Xu","year":"2019","journal-title":"BMC Cancer"},{"key":"R25-20250731","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.4161\/cc.9.18.13131","article-title":"Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status","volume":"9","author":"Vazquez-Martin","year":"2010","journal-title":"Cell Cycle"},{"key":"R26-20250731","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1186\/s12885-019-5945-1","article-title":"Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3\/NF-\u03baB pathways","volume":"19","author":"Esparza-L\u00f3pez","year":"2019","journal-title":"BMC Cancer"},{"key":"R27-20250731","doi-asserted-by":"crossref","first-page":"e62154","DOI":"10.1371\/journal.pone.0062154","article-title":"Increased Tc22 and Treg\/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"R28-20250731","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/bjd.13172","article-title":"Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+\/Foxp3+ CD25+ ratio","volume":"172","author":"Azzimonti","year":"2015","journal-title":"Br J Dermatol"},{"key":"R29-20250731","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pag\u00e8s","year":"2018","journal-title":"Lancet"},{"key":"R30-20250731","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/DAD.0000000000001437","article-title":"PD-L1 expression is increased in metastasizing squamous cell carcinomas and their metastases","volume":"41","author":"Garc\u00eda-D\u00edez","year":"2019","journal-title":"Am J Dermatopathol"},{"key":"R31-20250731","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1111\/ajco.13102","article-title":"Association between PD-L1 expression and lymph node metastasis in cutaneous squamous cell carcinoma","volume":"16","author":"Kamiya","year":"2020","journal-title":"Asia Pac J Clin Oncol"},{"key":"R32-20250731","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaad.2017.05.047","article-title":"Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck","volume":"77","author":"Garc\u00eda-Pedrero","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R33-20250731","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/0194599818788057","article-title":"PD-L1 expression and tumor-infiltrating lymphocytes in high-risk and metastatic cutaneous squamous cell carcinoma","volume":"160","author":"Amoils","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R34-20250731","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/cup.12728","article-title":"PD-L1 expression in cutaneous squamous cell carcinoma correlates with risk of metastasis","volume":"43","author":"Slater","year":"2016","journal-title":"J Cutan Pathol"},{"key":"R35-20250731","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.4103\/jcrt.JCRT_1290_16","article-title":"Checkpoint immunotherapy by nivolumab for treatment of metastatic melanoma","volume":"14","author":"Koppolu","year":"2018","journal-title":"J Cancer Res Ther"},{"issue":"Suppl 1","key":"R36-20250731","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1634\/theoncologist.2019-IO-S1-s05","article-title":"PD-1\/PD-L1 blockade therapy in advanced non-small-cell lung cancer: current status and future directions","volume":"24","author":"Xia","year":"2019","journal-title":"Oncologist"},{"key":"R37-20250731","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma","volume":"379","author":"Migden","year":"2018","journal-title":"N Engl J Med"},{"key":"R38-20250731","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1182\/blood-2017-02-765685","article-title":"Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL","volume":"129","author":"Ding","year":"2017","journal-title":"Blood"},{"key":"R39-20250731","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N Engl J Med"},{"key":"R40-20250731","first-page":"e71","article-title":"Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1\/2 trial","volume":"20","author":"Sharma","year":"2019","journal-title":"Lancet Oncol"},{"issue":"Suppl 4","key":"R41-20250731","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0959-8049(01)00230-1","article-title":"The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities","volume":"37","author":"Yarden","year":"2001","journal-title":"Eur J Cancer"},{"key":"R42-20250731","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.humpath.2007.07.004","article-title":"Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma","volume":"39","author":"Ch'ng","year":"2008","journal-title":"Hum Pathol"},{"key":"R43-20250731","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/bjd.14936","article-title":"Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma","volume":"176","author":"Ca\u00f1ueto","year":"2017","journal-title":"Br J Dermatol"},{"key":"R44-20250731","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000051637","article-title":"Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin","volume":"202","author":"Shimizu","year":"2001","journal-title":"Dermatology"},{"key":"R45-20250731","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/hed.21802","article-title":"EGFR expression in advanced head and neck cutaneous squamous cell carcinoma","volume":"34","author":"Sweeny","year":"2012","journal-title":"Head Neck"},{"key":"R46-20250731","first-page":"909","article-title":"Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma","volume":"2","author":"Kitagawa","year":"1996","journal-title":"Clin Cancer Res"},{"key":"R47-20250731","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/BF00866920","article-title":"Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis","volume":"242","author":"Diedrich","year":"1995","journal-title":"J Neurol"},{"key":"R48-20250731","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0022-4731(89)90072-1","article-title":"Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu","volume":"34","author":"Harris","year":"1989","journal-title":"J Steroid Biochem"},{"key":"R49-20250731","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/annonc\/mdu368","article-title":"Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma","volume":"25","author":"Foote","year":"2014","journal-title":"Ann Oncol"},{"key":"R50-20250731","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/cncr.31346","article-title":"Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: a single-arm phase 2 clinical trial","volume":"124","author":"Gold","year":"2018","journal-title":"Cancer"},{"key":"R51-20250731","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1470-2045(11)70318-7","article-title":"EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study","volume":"13","author":"Pirker","year":"2012","journal-title":"Lancet Oncol"},{"key":"R52-20250731","first-page":"3","article-title":"Epidermal growth factor receptor inhibitors and skin rash","volume":"39","author":"Ross","year":"2014","journal-title":"US Pharm"},{"key":"R53-20250731","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1634\/theoncologist.10-5-345","article-title":"HER1\/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1\/EGFR inhibitor rash management forum","volume":"10","author":"P\u00e9rez-Soler","year":"2005","journal-title":"Oncologist"},{"key":"R54-20250731","first-page":"196","article-title":"Rash severity is predictive of increased survival with erlotinib HCl [abstract]","volume":"22","author":"Clark","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"R55-20250731","first-page":"3766S","article-title":"Acne-like rash predicts response in patients treated with cetuximab (IMC-C225) plus irinotecan (CPT-11) in CPT-11-refractory colorectal cancer (CRC) that expresses epidermal growth factor receptor (EGFR)","volume":"559","author":"Saltz","year":"2001","journal-title":"Proc NCI-AACR-EORTC"},{"key":"R56-20250731","first-page":"204","article-title":"The presence and intensity of the cetuximab-induced acne-like rash predicts increased survival in studies across multiple malignancies","volume":"22","author":"Saltz","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"R57-20250731","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0092-8674(00)81879-6","article-title":"CDK-independent activation of estrogen receptor by cyclin D1","volume":"88","author":"Zwijsen","year":"1997","journal-title":"Cell"},{"key":"R58-20250731","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1074\/jbc.M106399200","article-title":"Cyclin D1: mechanism and consequence of androgen receptor co-repressor activity","volume":"277","author":"Petre","year":"2002","journal-title":"J Biol Chem"},{"key":"R59-20250731","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00109-016-1475-3","article-title":"Cyclin D1, cancer progression, and opportunities in cancer treatment","volume":"94","author":"Qie","year":"2016","journal-title":"J Mol Med (Berl)"},{"key":"R60-20250731","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2230.2011.04275.x","article-title":"Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma","volume":"37","author":"Huang","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"R61-20250731","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/1066896909336018","article-title":"PGP 9.5 and cyclin D1 coexpression in cutaneous squamous cell carcinomas","volume":"17","author":"Mastoraki","year":"2009","journal-title":"Int J Surg Pathol"},{"key":"R62-20250731","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-14-1773","article-title":"Genomic analysis of metastatic cutaneous squamous cell carcinoma","volume":"21","author":"Li","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R63-20250731","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.celrep.2019.02.023","article-title":"MicroRNA-mediated suppression of the TGF-\u03b2 pathway confers transmissible and reversible CDK4\/6 inhibitor resistance","volume":"26","author":"Cornell","year":"2019","journal-title":"Cell Rep"},{"key":"R64-20250731","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13737-014-0022-4","article-title":"Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?","volume":"4","author":"Geissler","year":"2015","journal-title":"Transpl Res"},{"key":"R65-20250731","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3390\/jcm4061229","article-title":"Cutaneous squamous cell carcinomas in organ transplant recipients","volume":"4","author":"Chockalingam","year":"2015","journal-title":"J Clin Med"},{"key":"R66-20250731","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archderm.139.3.301","article-title":"Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study","volume":"139","author":"Martinez","year":"2003","journal-title":"Arch Dermatol"},{"key":"R67-20250731","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/annonc\/mdw130","article-title":"Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma","volume":"27","author":"Spain","year":"2016","journal-title":"Ann Oncol"},{"key":"R68-20250731","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00262-016-1918-2","article-title":"Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report","volume":"66","author":"Owonikoko","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"R69-20250731","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMc1509268","article-title":"Tumor regression and allograft rejection after administration of anti-PD-1","volume":"374","author":"Lipson","year":"2016","journal-title":"N Engl J Med"},{"key":"R70-20250731","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jaad.2019.07.005","article-title":"Immune checkpoint inhibitor therapy in solid organ transplant recipients: a patient-centered systematic review","volume":"82","author":"Fisher","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R71-20250731","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamadermatol.2019.0032","article-title":"Performance of the American joint committee on cancer staging manual, 8th edition vs the brigham and women's hospital tumor classification system for cutaneous squamous cell carcinoma","volume":"155","author":"Ruiz","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R72-20250731","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1346-8138.2005.tb00906.x","article-title":"Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma","volume":"32","author":"Suiqing","year":"2005","journal-title":"J Dermatol"},{"key":"R73-20250731","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1007\/s13277-013-0961-2","article-title":"Tumor suppressor in lung cancer 1 (TSLC1), a novel tumor suppressor gene, is implicated in the regulation of proliferation, invasion, cell cycle, apoptosis, and tumorigenicity in cutaneous squamous cell carcinoma","volume":"34","author":"Liu","year":"2013","journal-title":"Tumour Biol"},{"key":"R74-20250731","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1365-2230.2012.04365.x","article-title":"Overexpression of RNA helicase p68 protein in cutaneous squamous cell carcinoma","volume":"37","author":"Wang","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"R75-20250731","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.0303-6987.2004.0158.x","article-title":"Ets-1 immunohistochemical expression in non-melanoma skin carcinoma","volume":"31","author":"Keehn","year":"2004","journal-title":"J Cutan Pathol"},{"key":"R76-20250731","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/hed.25556","article-title":"Correlation of focal adhesion kinase expression with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma","volume":"41","author":"Mungu\u00eda-Calzada","year":"2019","journal-title":"Head Neck"},{"key":"R77-20250731","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5021\/ad.2009.21.4.382","article-title":"The expression of NMDA receptor 1 correlates with clinicopathological parameters in cutaneous squamous cell carcinoma","volume":"21","author":"Kang","year":"2009","journal-title":"Ann Dermatol"},{"key":"R78-20250731","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0194599816641913","article-title":"Biomarker and pathologic predictors of cutaneous squamous cell carcinoma aggressiveness","volume":"155","author":"Khandelwal","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R79-20250731","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1158\/1940-6207.CAPR-10-0058","article-title":"Loss of inositol polyphosphate 5-phosphatase is an early event in development of cutaneous squamous cell carcinoma","volume":"3","author":"Sekulic","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"R80-20250731","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/carcin\/bgz054","article-title":"The Polycomb proteins RING1B and EZH2 repress the tumoral pro-inflammatory function in metastasizing primary cutaneous squamous cell carcinoma","volume":"40","author":"Hern\u00e1ndez-Ruiz","year":"2019","journal-title":"Carcinogenesis"},{"key":"R81-20250731","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00042728-200504000-00008","article-title":"LRIG-1 provides a novel prognostic predictor in squamous cell carcinoma of the skin: immunohistochemical analysis for 38 cases","volume":"31","author":"Tanemura","year":"2005","journal-title":"Dermatol Surg"},{"key":"R82-20250731","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00403-019-01916-x","article-title":"Lectin-like transcript 1 (LLT1) expression is associated with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma","volume":"311","author":"Santos-Juanes","year":"2019","journal-title":"Arch Dermatol Res"},{"key":"R83-20250731","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/bjd.13226","article-title":"Overexpression of p300 correlates with poor prognosis in patients with cutaneous squamous cell carcinoma","volume":"172","author":"Chen","year":"2015","journal-title":"Br J Dermatol"},{"key":"R84-20250731","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1365-2133.2006.07362.x","article-title":"Heat shock protein 105 is overexpressed in squamous cell carcinoma and extramammary Paget disease but not in basal cell carcinoma","volume":"155","author":"Muchemwa","year":"2006","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"R85-20250731","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0140-6736(15)60374-9","article-title":"Characteristics of immunosuppressive regulatory T cells in cutaneous squamous cell carcinomas and role in metastasis","volume":"385","author":"Lai","year":"2015","journal-title":"Lancet"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:11:50Z","timestamp":1753999910000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000002850","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,3]]}}}